Compare GKOS & VAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | VAL |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | Bermuda |
| Employees | N/A | 5070 |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.4B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | VAL |
|---|---|---|
| Price | $146.06 | $75.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | ★ $126.92 | $64.00 |
| AVG Volume (30 Days) | 928.7K | ★ 937.3K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.32 | N/A |
| Revenue Next Year | $27.43 | $15.76 |
| P/E Ratio | ★ N/A | $16.22 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $43.53 |
| 52 Week High | $148.62 | $114.12 |
| Indicator | GKOS | VAL |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 34.73 |
| Support Level | $96.44 | $47.57 |
| Resistance Level | N/A | $104.05 |
| Average True Range (ATR) | 5.65 | 2.96 |
| MACD | 1.60 | -0.52 |
| Stochastic Oscillator | 98.92 | 19.92 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.